BAX

#944
Baxter International Inc.
17.80 USD
+1.08%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
17.79
17.86
Rango anual
15.73
32.68
Cambio diario
+1.08%
Variación mensual
+3.43%
Variación en los últimos 6 meses
-21.83%
Cambio anual
-37.26%
Cierres anteriores
17.61
Abrir
17.80
Bid
Ask
Mínimo
17.79
High
17.86
Volumen
318
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 9.16 B
  • Employee 38 K
  • Founded N/A
  • CEO Andrew Hider
  • Website www.baxter.com
  • Headquarter Delaware, United States
  • FIGI BBG000BCVJ77
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-10.22
Relación precio/flujo de caja
0.87
Dividendos por acción
0.52
Rendimiento por dividendo, %
2.72

Baxter International Inc

Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals. Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients. Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services". Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology.

Noticias